Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAPYQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,260
Award facts
- Contract value 100% obligated
- $15,260.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,260.04 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen 2ml on July 22, 2025, with completion targeted for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
This delivery order exemplifies AmerisourceBergen Drug Corp's ongoing role as a primary pharmaceutical provider for federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The award reflects the contractor's established capability to deliver specialty medications and brand-name pharmaceuticals through competitive procurement processes. Cosentyx is a specialty biologic medication used in immunological treatments, consistent with the company's portfolio of therapeutic products spanning diabetes medications, neurological treatments, pain management pharmaceuticals, and other specialized healthcare commodities that support military and veteran healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FAPYQ?
SPE2DB25FAPYQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FAPYQ worth?
The government has obligated $15,260 on SPE2DB25FAPYQ.
Is contract SPE2DB25FAPYQ an order under another contract?
Yes. SPE2DB25FAPYQ is a delivery order under SPE2DB24D2105, an indefinite delivery contract.
Was contract SPE2DB25FAPYQ competed?
The extent of competition for SPE2DB25FAPYQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award